Lin N - Search Results

1

DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors.

Li Y, Zhou D, Xu S, Rao M, Zhang Z, Wu L, Zhang C, Lin N. Li Y, et al. Among authors: lin n. Cancer Biol Med. 2020 May 15;17(2):387-400. doi: 10.20892/j.issn.2095-3941.2019.0380. Cancer Biol Med. 2020. PMID: 32587776 Free PMC article.

2

Enhanced anti-tumor activity by the combination of TRAIL/Apo-2L and combretastatin A-4 against human colon cancer cells via induction of apoptosis in vitro and in vivo.

Zhang C, Wu R, Zhu H, Hu YZ, Jiang H, Lin NM, He QJ, Yang B. Zhang C, et al. Cancer Lett. 2011 Mar 1;302(1):11-9. doi: 10.1016/j.canlet.2010.12.001. Epub 2011 Jan 14. Cancer Lett. 2011. PMID: 21236562

3

Synergistic antitumor activity of gemcitabine and ABT-737 in vitro and in vivo through disrupting the interaction of USP9X and Mcl-1.

Zhang C, Cai TY, Zhu H, Yang LQ, Jiang H, Dong XW, Hu YZ, Lin NM, He QJ, Yang B. Zhang C, et al. Mol Cancer Ther. 2011 Jul;10(7):1264-75. doi: 10.1158/1535-7163.MCT-10-1091. Epub 2011 May 12. Mol Cancer Ther. 2011. PMID: 21566062

4

GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.

Zheng L, Yang W, Zhang C, Ding WJ, Zhu H, Lin NM, Wu HH, He QJ, Yang B. Zheng L, et al. Cancer Lett. 2011 Oct 1;309(1):27-36. doi: 10.1016/j.canlet.2011.05.011. Epub 2011 Jun 12. Cancer Lett. 2011. PMID: 21664043

5

In vitro anti-cancer activity of chamaejasmenin B and neochamaejasmin C isolated from the root of Stellera chamaejasme L.

Zhang C, Zhou SS, Feng LY, Zhang DY, Lin NM, Zhang LH, Pan JP, Wang JB, Li J. Zhang C, et al. Acta Pharmacol Sin. 2013 Feb;34(2):262-70. doi: 10.1038/aps.2012.158. Epub 2012 Dec 10. Acta Pharmacol Sin. 2013. PMID: 23222270 Free PMC article.

6

Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.

Ying M, Zhou X, Zhong L, Lin N, Jing H, Luo P, Yang X, Song H, Yang B, He Q. Ying M, et al. Among authors: lin n. Mol Cancer Ther. 2013 Feb;12(2):195-206. doi: 10.1158/1535-7163.MCT-12-0433. Epub 2012 Dec 13. Mol Cancer Ther. 2013. PMID: 23243061

7

Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo.

Zhang C, Zhou SS, Li XR, Wang BM, Lin NM, Feng LY, Zhang DY, Zhang LH, Wang JB, Pan JP. Zhang C, et al. Oncol Rep. 2013 Jun;29(6):2275-82. doi: 10.3892/or.2013.2405. Epub 2013 Apr 12. Oncol Rep. 2013. PMID: 23588374

8

Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.

Sheng L, Luo M, Sun X, Lin N, Mao W, Su D. Sheng L, et al. Among authors: lin n. Int J Cancer. 2013 Dec 1;133(11):2720-5. doi: 10.1002/ijc.28284. Epub 2013 Jun 14. Int J Cancer. 2013. PMID: 23716344

9

S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro.

Xu YS, Feng JG, Zhang D, Zhang B, Luo M, Su D, Lin NM. Xu YS, et al. Acta Pharmacol Sin. 2014 Feb;35(2):267-74. doi: 10.1038/aps.2013.176. Epub 2013 Dec 23. Acta Pharmacol Sin. 2014. PMID: 24362328 Free PMC article.

10

Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737.

Zhang C, Shi J, Mao SY, Xu YS, Zhang D, Feng LY, Zhang B, Yan YY, Wang SC, Pan JP, Yang YP, Lin NM. Zhang C, et al. J Cell Mol Med. 2015 Feb;19(2):408-17. doi: 10.1111/jcmm.12461. Epub 2014 Nov 11. J Cell Mol Med. 2015. PMID: 25388762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,029 results

Search Page

Filters